Krilogy Financial LLC Invests $453,000 in Cardinal Health, Inc. $CAH

Krilogy Financial LLC purchased a new stake in shares of Cardinal Health, Inc. (NYSE:CAH) during the 3rd quarter, Holdings Channel reports. The fund purchased 2,887 shares of the company’s stock, valued at approximately $453,000.

A number of other institutional investors have also added to or reduced their stakes in the stock. Geode Capital Management LLC grew its stake in shares of Cardinal Health by 3.3% during the second quarter. Geode Capital Management LLC now owns 6,389,049 shares of the company’s stock worth $1,069,005,000 after buying an additional 205,539 shares during the last quarter. Norges Bank bought a new position in shares of Cardinal Health in the 2nd quarter valued at $584,420,000. Invesco Ltd. grew its position in Cardinal Health by 7.3% during the 2nd quarter. Invesco Ltd. now owns 3,037,782 shares of the company’s stock worth $510,347,000 after acquiring an additional 207,750 shares during the last quarter. Legal & General Group Plc grew its position in Cardinal Health by 2.0% during the 2nd quarter. Legal & General Group Plc now owns 2,349,767 shares of the company’s stock worth $394,761,000 after acquiring an additional 45,812 shares during the last quarter. Finally, Marshall Wace LLP raised its position in Cardinal Health by 19.1% in the second quarter. Marshall Wace LLP now owns 1,930,967 shares of the company’s stock valued at $324,402,000 after purchasing an additional 309,335 shares during the last quarter. 87.17% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several analysts have recently weighed in on the company. Citigroup upgraded Cardinal Health from a “neutral” rating to a “buy” rating and boosted their price target for the stock from $190.00 to $244.00 in a report on Friday, January 9th. Argus upped their price target on shares of Cardinal Health from $232.00 to $248.00 and gave the company a “buy” rating in a research report on Wednesday. Weiss Ratings reaffirmed a “buy (b)” rating on shares of Cardinal Health in a research note on Wednesday, January 21st. Deutsche Bank Aktiengesellschaft lifted their price target on shares of Cardinal Health from $195.00 to $208.00 and gave the stock a “hold” rating in a report on Tuesday, November 18th. Finally, Evercore ISI increased their price objective on Cardinal Health from $250.00 to $260.00 in a report on Friday, February 6th. One equities research analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and two have assigned a Hold rating to the company. According to MarketBeat.com, Cardinal Health has a consensus rating of “Moderate Buy” and a consensus price target of $245.19.

Cardinal Health Stock Performance

Shares of NYSE CAH opened at $220.72 on Friday. The company’s 50 day moving average price is $208.84 and its 200-day moving average price is $182.37. Cardinal Health, Inc. has a 52-week low of $120.72 and a 52-week high of $230.81. The company has a market capitalization of $51.94 billion, a P/E ratio of 31.76, a price-to-earnings-growth ratio of 1.42 and a beta of 0.64.

Cardinal Health (NYSE:CAH) last announced its earnings results on Thursday, February 5th. The company reported $2.63 earnings per share for the quarter, topping analysts’ consensus estimates of $2.31 by $0.32. The business had revenue of $65.63 billion during the quarter, compared to the consensus estimate of $64.88 billion. Cardinal Health had a net margin of 0.68% and a negative return on equity of 92.50%. Cardinal Health’s quarterly revenue was up 18.8% on a year-over-year basis. During the same quarter last year, the firm earned $1.93 earnings per share. Analysts forecast that Cardinal Health, Inc. will post 7.95 earnings per share for the current year.

Cardinal Health Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, April 15th. Investors of record on Wednesday, April 1st will be given a dividend of $0.5107 per share. The ex-dividend date is Wednesday, April 1st. This represents a $2.04 annualized dividend and a dividend yield of 0.9%. Cardinal Health’s dividend payout ratio is presently 29.35%.

Key Stories Impacting Cardinal Health

Here are the key news stories impacting Cardinal Health this week:

• Positive Sentiment: Recent quarterly results and underlying strength — Cardinal reported a Q4 EPS beat and revenue above expectations, with revenue up ~19% year-over-year, which analysts cite as supporting the stock’s upside. Cardinal Health’s (NYSE:CAH) Solid Earnings Are Supported By Other Strong Factors
• Positive Sentiment: Dividend confirmed — the Board approved a quarterly dividend of $0.5107 per share (payable Apr 15; record Apr 1). The cash return reinforces income appeal and signals confidence in cash flow. Cardinal Health Board of Directors Approves Quarterly Dividend
• Positive Sentiment: Analyst lift — JPMorgan raised its price target to $243, providing a tangible upside anchor for investors and helping sentiment. JPMorgan Chase Increases Cardinal Health Price Target
• Positive Sentiment: Zacks momentum & valuation coverage — CAH was added to Zacks’ Rank #1 momentum list and several Zacks pieces highlight undervaluation and a favorable long-term value case, which can attract momentum and value investors. Best Momentum Stock to Buy for February 13th Are Investors Undervaluing Cardinal Health?
• Neutral Sentiment: Kalkine notes logistics/reliability improvements on the NYSE composite — operational reliability updates are constructive but are incremental near-term drivers. Cardinal Health Boosts Logistics Reliability
• Neutral Sentiment: Analyst Q&A from the earnings call — the transcript highlights management’s priorities and risk items; useful for longer-term fundamental assessment but not an immediate catalyst. The 5 Most Interesting Analyst Questions From Cardinal Health’s Q4 Earnings Call

About Cardinal Health

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.